Prestige Consumer Healthcare (PBH) Finished Goods (2012 - 2019)
Prestige Consumer Healthcare's (PBH) quarterly Finished Goods came in at $102.6 million in Q1 2019, down 2.51% year-on-year from $105.3 million in Q1 2018, and up 3.02% quarter-over-quarter from $99.6 million in Q3 2018.
Prestige Consumer Healthcare (PBH) Finished Goods (2012 - 2019) Analysis & Trends
Prestige Consumer Healthcare's Finished Goods history runs 8 years deep, the most recent figure standing at $102.6 million for Q1 2019.
- On a quarterly basis, Finished Goods fell 2.51% year-over-year to $102.6 million in Q1 2019; TTM through Mar 2019 was $102.6 million, a 2.51% decrease from a year earlier, with the FY2019 full-year figure at $102.6 million, down 2.51% from the prior year.
- Finished Goods improved to $102.6 million in Q1 2019 per PBH's latest filing, from $99.6 million in the prior quarter.
- Across five years, Finished Goods topped out at $105.3 million in Q1 2018 and bottomed at $66.3 million in Q2 2015.
- The 5-year median for Finished Goods is $87.9 million (2016), against an average of $86.8 million.
- Across the five-year window, Finished Goods retreated 6.33% in 2015 and grew 28.79% in 2016, its largest moves.
- Year by year, Finished Goods stood at $72.6 million in 2015, then gained by 28.12% to $93.0 million in 2016, then rose by 13.2% to $105.3 million in 2017, then retreated by 5.35% to $99.6 million in 2018, then increased by 3.02% to $102.6 million in 2019.
- Per Business Quant, the three latest PBH Finished Goods figures stand at $102.6 million (Q1 2019), $99.6 million (Q3 2018), and $105.3 million (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 102.64 Mn |
| Sep 30, 2018 | 99.63 Mn |
| Mar 31, 2018 | 105.28 Mn |
| Mar 31, 2017 | 105.26 Mn |
| Dec 31, 2016 | 92.98 Mn |
| Sep 30, 2016 | 90.41 Mn |
| Jun 30, 2016 | 85.43 Mn |
| Mar 31, 2016 | 83.70 Mn |
| Dec 31, 2015 | 72.57 Mn |
| Sep 30, 2015 | 70.71 Mn |
| Jun 30, 2015 | 66.33 Mn |
| Mar 31, 2015 | 66.41 Mn |
| Dec 31, 2014 | 68.33 Mn |
| Sep 30, 2014 | 75.49 Mn |
| Jun 30, 2014 | 64.11 Mn |
| Mar 31, 2014 | 62.49 Mn |
| Dec 31, 2013 | 63.34 Mn |
| Sep 30, 2013 | 60.90 Mn |
| Jun 30, 2013 | 65.75 Mn |
| Mar 31, 2013 | 58.33 Mn |